GetTopicDetailResponse(id=a89910e255e, topicName=lazertinib, introduction=lazertinib, content=null, image=null, comments=0, allHits=671, url=https://h5.medsci.cn/topic?id=10725, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95369, tagList=[TagDto(tagId=95369, tagName=lazertinib)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2273289, encodeId=54a722e3289f8, content=<a href='/topic/show?id=4f2113501a7' target=_blank style='color:#2F92EE;'>#osimertinib#</a> <a href='/topic/show?id=a89910e255e' target=_blank style='color:#2F92EE;'>#lazertinib#</a> <a href='/topic/show?id=253b12856035' target=_blank style='color:#2F92EE;'>#EGFR突變晚期非小細(xì)胞肺癌#</a>, objectTitle=Lazertinib Vs Osimertinib：MARIPOSA研究探索EGFR突變晚期非小細(xì)胞肺癌初治患者的療效和安全性比較, objectType=article, longId=886555, objectId=ed7188655534, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250122/1737525065730_8538692.png, objectUrl=/article/show_article.do?id=ed7188655534, replyNumber=0, likeNumber=31, createdTime=2025-07-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ed7188655534, moduleTitle=Lazertinib Vs Osimertinib：MARIPOSA研究探索EGFR突變晚期非小細(xì)胞肺癌初治患者的療效和安全性比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ed7188655534)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223797, encodeId=6eac2223e9796, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=4f2113501a7' target=_blank style='color:#2F92EE;'>#osimertinib#</a> <a href='/topic/show?id=a89910e255e' target=_blank style='color:#2F92EE;'>#lazertinib#</a> <a href='/topic/show?id=15611080035b' target=_blank style='color:#2F92EE;'>#amivantamab#</a> <a href='/topic/show?id=648d118539fc' target=_blank style='color:#2F92EE;'>#WCLC 2024#</a>, objectTitle=WCLC 2024 ：Amivantamab聯(lián)合Lazertinib對(duì)比Osimertinib一線治療EGFR突變NSCLC展現(xiàn)更優(yōu)療效（MARIPOSA研究）, objectType=article, longId=841653, objectId=6f9c841653a4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240902/1725290369209_8624274.png, objectUrl=/article/show_article.do?id=6f9c841653a4, replyNumber=0, likeNumber=129, createdTime=2024-09-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6f9c841653a4, moduleTitle=WCLC 2024 ：Amivantamab聯(lián)合Lazertinib對(duì)比Osimertinib一線治療EGFR突變NSCLC展現(xiàn)更優(yōu)療效（MARIPOSA研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6f9c841653a4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223544, encodeId=b9e12223544d5, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a> <a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a> <a href='/topic/show?id=a89910e255e' target=_blank style='color:#2F92EE;'>#lazertinib#</a>, objectTitle=JAMA子刊：肺癌腦轉(zhuǎn)移控制率近100%，第三代EGFR靶向藥后線治療再添證據(jù), objectType=article, longId=841429, objectId=ee7684142914, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720666430467_5579292.jpg, objectUrl=/article/show_article.do?id=ee7684142914, replyNumber=0, likeNumber=119, createdTime=2024-09-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ee7684142914, moduleTitle=JAMA子刊：肺癌腦轉(zhuǎn)移控制率近100%，第三代EGFR靶向藥后線治療再添證據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ee7684142914)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
